[2020]

• Kim Y, Kang S, Shin H, Kim TW, Yu B, Kim J, Yoo D, Jon S*, ​"Sequential and timely combination of cancer nanovaccine with immune checkpoint blockade effectively inhibits tumor growth and relapse", Angew. Chem. Int. Ed., 2020, ange.202006117 (IF: 12.257) (2020 May 25).

• Chung CH, Jung W, Keum H, Kim TW, Jon S*, "Nanoparticles Derived From the Natural Antioxidant, Rosmarinic Acid, Ameliorate Acute Inflammatory Bowel Disease", ACS Nano, 2020, 0c01018 (IF: 13.903) (2020 May 25).

• Noh, I, Kim MS, Kim J, Lee DY, Oh D, Kim C, Jon S, Kim YC*, "Structure-inherent near-infrared bilayer nanovesicles for use as photoacoustic image-guided chemo-thermotherapy", J. Control. Release​, 2020, 320, 283-292. (IF: 7.877)

• Kim J, Keum H, Kim H, Yu B, Jung W, Whang CH, Seo C, Park JH, Jon S*​, "Gold nanorods with an ultrathin anti-biofouling siloxane layer for combinatorial anticancer therapy", J. Drug Target, 2020, 10.1080/1061186X.2020.1737086. (IF: 3.408)

• AMJ Haque, P Nandhakumar, G Kim, S Park, B Yu, NS Lee YH Yoon, S Jon, H Yang*, "Diaphorase-Catalyzed Formation of a Formazan Precipitate and Its Electrodissolution for Sensitive Affinity Biosensors", Anal. Chem., 2020, 92, 5, 3932-3939. (IF: 6.350)

• DY Lee, S Kang, Y Lee, JY Kim, D Yoo, W Jung, S Lee, YY Jeong, K Lee, S Jon*, "PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood", Theranostics, 2020, 10 (5), 1997. (IF: 8.712)

[2019]

• J Yoo, NS Rejinold, DY Lee, I Noh, WG Koh, S Jon, YC Kim*, "CD44-mediated methotrexate delivery by hyaluronan coated nanoparticles composed of a branched cell-penetrating peptide", ACS Biomater. Sci. Eng., 2020, 6, 1, 494-504. (IF: 2.78)

• C Jeong, I Noh, NS Rejinold, J Kim, S Jon, YC Kim*, "Self-assembled supramolecular bilayer nanoparticles composed of near-infrared dye as a theranostic nanoplatform to encapsulate hydrophilic drugs effectively", ACS Biomater. Sci. Eng., 2020, 6, 1, 474-484. (IF: 2.78)

• Y Lee, K Sugihara, MG Gillilland, S Jon, N Kamada, JJ Moon*, "Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis", Nat. Mater.,19, 118-126. (IF: 38.887)

• Saw PE*, Lee S, Jon S*, “Naturally Occurring Bioactive Compound-Derived Nanoparticles for Biomedical Applications”, Adv. Therap. 2019; 2, 1800146 (IF: ) (Epub Feb 25) (IF:)

• Kim DY, Hwang K, Ahn J, Seo YH, Kim JB, Lee S, Yoon JH, Kong E, Jeong Y, Jon S, Kim P and Jeong KH*, “Lissajous Scanning Two-photon Endomicroscope for In vivo Tissue Imaging”, Sci. Rep. 2019; 9(1), 3560 (IF: 4.122) (2019 Mar 5).

• Yu B, Hwang D, Jeon H, Kim H, Lee Y, Keum H, Kim J, Lee DY, Kim Y, Chung J and Jon S*, “A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy”, Angew. Chem. Int. Ed. 2019; 58(7), 2005-2010. (IF: 12.102) (Epub 2019 Jan 2; Feb 11).

• Kim H, Hwang DB, Choi M, Lee S, Kang S, Lee Y, Kim S, Chung J* and Jon S*, “Antibody-assisted delivery of a peptide-drug conjugate for targeted cancer therapy”, Mol Pharm. 2019; 16(1), 165-172. (IF: 4.556) (Epub 2018 Dec 6).